TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹30 Cr | ₹13 Cr | ₹3.41 Cr | ₹0.45 Cr |
What is the latest Total Non-Current Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹3.41 Cr |
| Mar2022 | ₹0.45 Cr |
How is Total Non-Current Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 138.92 | |
| Mar2024 | ₹13 Cr | 273.03 | |
| Mar2023 | ₹3.41 Cr | 652.98 | |
| Mar2022 | ₹0.45 Cr | - | |
Compare Total Non-Current Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹301.4 Cr | 1.5% | 2.1% | -14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 1.5% |
2.1% |
-14.2% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses